

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.22955056 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.90656182 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.19501273 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.19300254 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.19300254 |
| 6 | immunoglobulin mediated immune response (GO:0016064) | 4.89339098 |
| 7 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.79000340 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.69674494 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.54684136 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 4.53761790 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.44924789 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.44924789 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.44924789 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.44924789 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.44924789 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.44924789 |
| 17 | microglial cell activation (GO:0001774) | 4.35155547 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.32455429 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.32455429 |
| 20 | B cell receptor signaling pathway (GO:0050853) | 4.20365646 |
| 21 | regulation of B cell differentiation (GO:0045577) | 4.19265455 |
| 22 | positive regulation of antigen processing and presentation (GO:0002579) | 4.18565705 |
| 23 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.14617174 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 4.13983176 |
| 25 | mature B cell differentiation involved in immune response (GO:0002313) | 4.09060261 |
| 26 | T cell selection (GO:0045058) | 4.02156211 |
| 27 | thymic T cell selection (GO:0045061) | 4.01771128 |
| 28 | positive T cell selection (GO:0043368) | 4.00436322 |
| 29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.92693904 |
| 30 | leukocyte aggregation (GO:0070486) | 3.91217256 |
| 31 | mast cell activation (GO:0045576) | 3.91016875 |
| 32 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.89551705 |
| 33 | mature B cell differentiation (GO:0002335) | 3.89386692 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.89156664 |
| 35 | detection of bacterium (GO:0016045) | 3.85709996 |
| 36 | response to interleukin-15 (GO:0070672) | 3.82559587 |
| 37 | B cell mediated immunity (GO:0019724) | 3.80310408 |
| 38 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.71863753 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.71678095 |
| 40 | positive regulation of interferon-alpha production (GO:0032727) | 3.71050020 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.66986580 |
| 42 | detection of other organism (GO:0098543) | 3.64553607 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.64303761 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.62042660 |
| 45 | positive regulation of isotype switching (GO:0045830) | 3.59554952 |
| 46 | regulation of interferon-alpha production (GO:0032647) | 3.57004945 |
| 47 | regulation of regulatory T cell differentiation (GO:0045589) | 3.55696565 |
| 48 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.52840819 |
| 49 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.52039090 |
| 50 | positive thymic T cell selection (GO:0045059) | 3.49595408 |
| 51 | regulation of antigen processing and presentation (GO:0002577) | 3.48297041 |
| 52 | negative regulation of granulocyte differentiation (GO:0030853) | 3.48022129 |
| 53 | positive regulation of granulocyte differentiation (GO:0030854) | 3.45298134 |
| 54 | regulation of gamma-delta T cell activation (GO:0046643) | 3.44364260 |
| 55 | respiratory burst (GO:0045730) | 3.41952549 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.39836018 |
| 57 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.38881754 |
| 58 | response to muramyl dipeptide (GO:0032495) | 3.38622258 |
| 59 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.37258547 |
| 60 | myeloid cell activation involved in immune response (GO:0002275) | 3.36290403 |
| 61 | pinocytosis (GO:0006907) | 3.36122560 |
| 62 | rhodopsin mediated signaling pathway (GO:0016056) | 3.35193851 |
| 63 | regulation of female gonad development (GO:2000194) | 3.30545994 |
| 64 | myeloid dendritic cell activation (GO:0001773) | 3.27664868 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.25646505 |
| 66 | type I interferon signaling pathway (GO:0060337) | 3.25646505 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.25314313 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.24668457 |
| 69 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.24329470 |
| 70 | response to type I interferon (GO:0034340) | 3.23871258 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.23553969 |
| 72 | negative regulation of macrophage differentiation (GO:0045650) | 3.23198980 |
| 73 | positive regulation of DNA recombination (GO:0045911) | 3.22455622 |
| 74 | response to peptidoglycan (GO:0032494) | 3.20370813 |
| 75 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.19753389 |
| 76 | positive regulation of B cell mediated immunity (GO:0002714) | 3.19753389 |
| 77 | defense response to protozoan (GO:0042832) | 3.19182868 |
| 78 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.15813219 |
| 79 | glycosphingolipid catabolic process (GO:0046479) | 3.14787328 |
| 80 | leukocyte degranulation (GO:0043299) | 3.14050311 |
| 81 | macrophage activation (GO:0042116) | 3.13274942 |
| 82 | regulation of T cell tolerance induction (GO:0002664) | 3.10000231 |
| 83 | response to protozoan (GO:0001562) | 3.09605137 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.07532650 |
| 85 | response to interferon-beta (GO:0035456) | 3.07420994 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07152240 |
| 87 | positive regulation of humoral immune response (GO:0002922) | 3.06798562 |
| 88 | positive regulation of interleukin-4 production (GO:0032753) | 3.06516033 |
| 89 | cellular response to zinc ion (GO:0071294) | 3.06411948 |
| 90 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.05987453 |
| 91 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.05911449 |
| 92 | T cell receptor signaling pathway (GO:0050852) | 3.03769802 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 3.02421363 |
| 94 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.02370217 |
| 95 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.02370217 |
| 96 | regulation of macrophage differentiation (GO:0045649) | 3.01274976 |
| 97 | activated T cell proliferation (GO:0050798) | 3.00912907 |
| 98 | cellular response to interferon-beta (GO:0035458) | 2.98988454 |
| 99 | granulocyte activation (GO:0036230) | 2.96933410 |
| 100 | oligosaccharide catabolic process (GO:0009313) | 2.96757997 |
| 101 | lymphocyte homeostasis (GO:0002260) | 2.95298285 |
| 102 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.94436163 |
| 103 | regulation of granulocyte differentiation (GO:0030852) | 2.93006075 |
| 104 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.92263345 |
| 105 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.91832742 |
| 106 | regulation of mast cell degranulation (GO:0043304) | 2.90862003 |
| 107 | regulation of mast cell activation (GO:0033003) | 2.90850721 |
| 108 | myeloid leukocyte activation (GO:0002274) | 2.89434470 |
| 109 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.88767054 |
| 110 | positive regulation of chemokine secretion (GO:0090197) | 2.87067496 |
| 111 | positive regulation of macrophage differentiation (GO:0045651) | 2.85330246 |
| 112 | cytidine metabolic process (GO:0046087) | 2.85092348 |
| 113 | cytidine catabolic process (GO:0006216) | 2.85092348 |
| 114 | cytidine deamination (GO:0009972) | 2.85092348 |
| 115 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.83537104 |
| 116 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.83537104 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83476767 |
| 118 | response to host (GO:0075136) | 2.83476767 |
| 119 | response to host defenses (GO:0052200) | 2.83476767 |
| 120 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.83294274 |
| 121 | neutrophil activation (GO:0042119) | 2.82971026 |
| 122 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.81759821 |
| 123 | positive regulation of immunoglobulin production (GO:0002639) | 2.81008737 |
| 124 | positive regulation of interferon-beta production (GO:0032728) | 2.80214537 |
| 125 | T cell homeostasis (GO:0043029) | 2.79135188 |
| 126 | negative regulation of metanephros development (GO:0072217) | 2.78780174 |
| 127 | NIK/NF-kappaB signaling (GO:0038061) | 2.78167156 |
| 128 | positive regulation of mast cell activation (GO:0033005) | 2.78165933 |
| 129 | regulation of tolerance induction (GO:0002643) | 2.77683365 |
| 130 | T cell costimulation (GO:0031295) | 2.77326308 |
| 131 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.77324283 |
| 132 | negative T cell selection (GO:0043383) | 2.76812499 |
| 133 | negative regulation of T cell apoptotic process (GO:0070233) | 2.76501195 |
| 134 | positive regulation of B cell activation (GO:0050871) | 2.76275303 |
| 135 | glycolipid catabolic process (GO:0019377) | 2.76093764 |
| 136 | megakaryocyte development (GO:0035855) | 2.75705973 |
| 137 | negative thymic T cell selection (GO:0045060) | 2.75288389 |
| 138 | response to host immune response (GO:0052572) | 2.75235818 |
| 139 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75235818 |
| 140 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.75016949 |
| 141 | lymphocyte costimulation (GO:0031294) | 2.73961837 |
| 142 | cellular extravasation (GO:0045123) | 2.73493281 |
| 143 | dendritic cell differentiation (GO:0097028) | 2.73285142 |
| 144 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.72879254 |
| 145 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.72338108 |
| 146 | regulation of interleukin-4 production (GO:0032673) | 2.72321631 |
| 147 | retinal cone cell development (GO:0046549) | 2.72042660 |
| 148 | tolerance induction (GO:0002507) | 2.69485201 |
| 149 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69481993 |
| 150 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.67095794 |
| 151 | lymphocyte mediated immunity (GO:0002449) | 2.66196485 |
| 152 | T cell migration (GO:0072678) | 2.65812085 |
| 153 | ribosomal small subunit assembly (GO:0000028) | 2.65644867 |
| 154 | mast cell activation involved in immune response (GO:0002279) | 2.65437612 |
| 155 | mast cell degranulation (GO:0043303) | 2.65437612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.32992644 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.22813978 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.44412151 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.89363626 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.72389293 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.65895267 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.64819063 |
| 8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.47769837 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.32375339 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.26188808 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18428429 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.82701692 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78866665 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.62884057 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.57136276 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.54534110 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.46920152 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.46535183 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46415833 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.37968310 |
| 21 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.36244554 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33034161 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.32580972 |
| 24 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32340723 |
| 25 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31126157 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27948580 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 2.20099560 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19126013 |
| 29 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.17141804 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10507881 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 2.01766374 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.00953833 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98636117 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.93761849 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.93373558 |
| 36 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.92339751 |
| 37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90921947 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89193649 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85980047 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82840344 |
| 41 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.80229409 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73312210 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68911058 |
| 44 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68545816 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67335767 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57906970 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53789963 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53374936 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50059138 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48791409 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48083974 |
| 52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48029604 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.44078642 |
| 54 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43419514 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42209839 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39178407 |
| 57 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38647805 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37012885 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34485739 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34373570 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.34205727 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33076368 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.32883056 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27877371 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27838958 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26737386 |
| 67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25215263 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21119252 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19550410 |
| 70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19411183 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19120629 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18045609 |
| 73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.17239970 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16485248 |
| 75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16084252 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14956426 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14175865 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13305187 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11280073 |
| 80 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.03801956 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00661696 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00621178 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98434780 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98250025 |
| 85 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98031957 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97581349 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96353283 |
| 88 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95886298 |
| 89 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95227601 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94078410 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93456047 |
| 92 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91627973 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91517013 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91339172 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89772302 |
| 96 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.89289369 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88783443 |
| 98 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87973422 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.86456358 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85448099 |
| 101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.84948265 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84243067 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83654297 |
| 104 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83088196 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82439549 |
| 106 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76729914 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76531167 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74714606 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74704089 |
| 110 | P300_27268052_Chip-Seq_Bcells_Human | 0.73228191 |
| 111 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72885355 |
| 112 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.72381169 |
| 113 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71562521 |
| 114 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.70682970 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.70567107 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69339756 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69035849 |
| 118 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.68236134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.06386521 |
| 2 | MP0005671_abnormal_response_to | 3.56049971 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.07627595 |
| 4 | MP0001800_abnormal_humoral_immune | 3.01639618 |
| 5 | MP0006082_CNS_inflammation | 2.96452775 |
| 6 | MP0003436_decreased_susceptibility_to | 2.90884329 |
| 7 | MP0002452_abnormal_antigen_presenting | 2.80484094 |
| 8 | MP0000685_abnormal_immune_system | 2.74887004 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.71796129 |
| 10 | MP0005387_immune_system_phenotype | 2.63677551 |
| 11 | MP0001790_abnormal_immune_system | 2.63677551 |
| 12 | MP0002723_abnormal_immune_serum | 2.63435096 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.62153586 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.61448244 |
| 15 | MP0009785_altered_susceptibility_to | 2.54806793 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.54567928 |
| 17 | MP0001819_abnormal_immune_cell | 2.53570946 |
| 18 | MP0002419_abnormal_innate_immunity | 2.50937789 |
| 19 | MP0002132_abnormal_respiratory_system | 2.49532152 |
| 20 | MP0005025_abnormal_response_to | 2.45711853 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.25572764 |
| 22 | MP0003011_delayed_dark_adaptation | 2.17784501 |
| 23 | MP0002398_abnormal_bone_marrow | 2.17571635 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.14501437 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.14398206 |
| 26 | MP0003303_peritoneal_inflammation | 2.11097029 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.08693595 |
| 28 | MP0003172_abnormal_lysosome_physiology | 2.08484273 |
| 29 | MP0000716_abnormal_immune_system | 2.04863829 |
| 30 | MP0002405_respiratory_system_inflammati | 1.92560080 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.91816133 |
| 32 | MP0005310_abnormal_salivary_gland | 1.91514713 |
| 33 | MP0003724_increased_susceptibility_to | 1.89460365 |
| 34 | MP0002722_abnormal_immune_system | 1.82868212 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.75045009 |
| 36 | MP0002429_abnormal_blood_cell | 1.74837285 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.72314411 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.69888815 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.67011029 |
| 40 | MP0004510_myositis | 1.65566815 |
| 41 | MP0001853_heart_inflammation | 1.62864084 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.59488766 |
| 43 | MP0003866_abnormal_defecation | 1.56342508 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.54519823 |
| 45 | MP0009278_abnormal_bone_marrow | 1.53354571 |
| 46 | MP0001873_stomach_inflammation | 1.47951548 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.47356849 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.47356849 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.46153375 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.44744638 |
| 51 | MP0008469_abnormal_protein_level | 1.41660905 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.35577641 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.32935547 |
| 54 | MP0008260_abnormal_autophagy | 1.32572441 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.31401011 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.31000465 |
| 57 | MP0008007_abnormal_cellular_replicative | 1.29078721 |
| 58 | MP0002933_joint_inflammation | 1.27034942 |
| 59 | MP0004381_abnormal_hair_follicle | 1.24699720 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.22307183 |
| 61 | MP0008004_abnormal_stomach_pH | 1.18103667 |
| 62 | MP0000490_abnormal_crypts_of | 1.18015436 |
| 63 | MP0004947_skin_inflammation | 1.16079887 |
| 64 | MP0000343_altered_response_to | 1.15794184 |
| 65 | MP0002006_tumorigenesis | 1.15119383 |
| 66 | MP0005253_abnormal_eye_physiology | 1.15071068 |
| 67 | MP0003045_fibrosis | 1.01395604 |
| 68 | MP0005410_abnormal_fertilization | 0.98880681 |
| 69 | MP0002998_abnormal_bone_remodeling | 0.96413557 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 0.95744739 |
| 71 | MP0005166_decreased_susceptibility_to | 0.93707744 |
| 72 | MP0000858_altered_metastatic_potential | 0.93005896 |
| 73 | MP0003075_altered_response_to | 0.90708075 |
| 74 | MP0001663_abnormal_digestive_system | 0.90153715 |
| 75 | MP0010094_abnormal_chromosome_stability | 0.87434450 |
| 76 | MP0001919_abnormal_reproductive_system | 0.86360424 |
| 77 | MP0009764_decreased_sensitivity_to | 0.86045301 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.85920208 |
| 79 | MP0001851_eye_inflammation | 0.84401622 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.83631203 |
| 81 | MP0008058_abnormal_DNA_repair | 0.83575107 |
| 82 | MP0003786_premature_aging | 0.83410999 |
| 83 | MP0003448_altered_tumor_morphology | 0.81578645 |
| 84 | MP0006072_abnormal_retinal_apoptosis | 0.81060851 |
| 85 | MP0001324_abnormal_eye_pigmentation | 0.80690653 |
| 86 | MP0009840_abnormal_foam_cell | 0.80275538 |
| 87 | MP0001764_abnormal_homeostasis | 0.79481673 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.77946885 |
| 89 | MP0003077_abnormal_cell_cycle | 0.76470705 |
| 90 | MP0009763_increased_sensitivity_to | 0.76165376 |
| 91 | MP0003943_abnormal_hepatobiliary_system | 0.73382246 |
| 92 | MP0002928_abnormal_bile_duct | 0.72651706 |
| 93 | MP0002090_abnormal_vision | 0.72429647 |
| 94 | MP0008057_abnormal_DNA_replication | 0.72284846 |
| 95 | MP0000569_abnormal_digit_pigmentation | 0.70796832 |
| 96 | MP0010307_abnormal_tumor_latency | 0.70614359 |
| 97 | MP0005451_abnormal_body_composition | 0.70566151 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.67743114 |
| 99 | MP0004147_increased_porphyrin_level | 0.67681361 |
| 100 | MP0001661_extended_life_span | 0.67505108 |
| 101 | MP0002009_preneoplasia | 0.66739106 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.65425840 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.65392522 |
| 104 | MP0000371_diluted_coat_color | 0.64387204 |
| 105 | MP0004883_abnormal_blood_vessel | 0.62710432 |
| 106 | MP0008877_abnormal_DNA_methylation | 0.62365795 |
| 107 | MP0008995_early_reproductive_senescence | 0.61469707 |
| 108 | MP0003252_abnormal_bile_duct | 0.60686900 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.60509879 |
| 110 | MP0000313_abnormal_cell_death | 0.60047931 |
| 111 | MP0003806_abnormal_nucleotide_metabolis | 0.60042280 |
| 112 | MP0003795_abnormal_bone_structure | 0.59632304 |
| 113 | MP0008873_increased_physiological_sensi | 0.58939794 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.57948312 |
| 115 | MP0003690_abnormal_glial_cell | 0.57595381 |
| 116 | MP0009643_abnormal_urine_homeostasis | 0.57410364 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.57342629 |
| 118 | MP0000249_abnormal_blood_vessel | 0.57296792 |
| 119 | MP0003828_pulmonary_edema | 0.57253582 |
| 120 | MP0000609_abnormal_liver_physiology | 0.57252984 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.56485985 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.55617742 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.54443159 |
| 124 | MP0003195_calcinosis | 0.54414167 |
| 125 | MP0005389_reproductive_system_phenotype | 0.54351346 |
| 126 | MP0002277_abnormal_respiratory_mucosa | 0.53670147 |
| 127 | MP0005083_abnormal_biliary_tract | 0.53067594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 5.67835809 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.19649840 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.85738426 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.66440764 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.52768527 |
| 6 | Gonadal dysgenesis (HP:0000133) | 4.31809694 |
| 7 | Stomatitis (HP:0010280) | 4.28072381 |
| 8 | IgM deficiency (HP:0002850) | 4.09779488 |
| 9 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.09575538 |
| 10 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.89422608 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.86452932 |
| 12 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.81887882 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.80697101 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.80697101 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.80697101 |
| 16 | Glomerulonephritis (HP:0000099) | 3.76912045 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.76897141 |
| 18 | T lymphocytopenia (HP:0005403) | 3.70653907 |
| 19 | Purpura (HP:0000979) | 3.58368096 |
| 20 | Testicular neoplasm (HP:0010788) | 3.53651376 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.48731844 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.46376943 |
| 23 | Colitis (HP:0002583) | 3.38275562 |
| 24 | Inflammation of the large intestine (HP:0002037) | 3.35709015 |
| 25 | Agammaglobulinemia (HP:0004432) | 3.35227087 |
| 26 | Myositis (HP:0100614) | 3.34100205 |
| 27 | Pigmentary retinal degeneration (HP:0001146) | 3.32624164 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.31449451 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 3.30413681 |
| 30 | Recurrent viral infections (HP:0004429) | 3.29171880 |
| 31 | Abnormal platelet volume (HP:0011876) | 3.27073798 |
| 32 | Gingival bleeding (HP:0000225) | 3.25124882 |
| 33 | Recurrent skin infections (HP:0001581) | 3.24427265 |
| 34 | Cellulitis (HP:0100658) | 3.17688516 |
| 35 | Recurrent fungal infections (HP:0002841) | 3.17472088 |
| 36 | Granulocytopenia (HP:0001913) | 3.14118793 |
| 37 | Increased IgM level (HP:0003496) | 3.13540337 |
| 38 | Abnormality of macrophages (HP:0004311) | 3.11501659 |
| 39 | Severe combined immunodeficiency (HP:0004430) | 3.08031809 |
| 40 | Chronic otitis media (HP:0000389) | 3.07431139 |
| 41 | Meningitis (HP:0001287) | 3.06272139 |
| 42 | Recurrent bronchitis (HP:0002837) | 3.04610276 |
| 43 | Thrombocytosis (HP:0001894) | 3.01137164 |
| 44 | Chronic diarrhea (HP:0002028) | 3.00269542 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.97458337 |
| 46 | Petechiae (HP:0000967) | 2.97108075 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.93299602 |
| 48 | Lymphopenia (HP:0001888) | 2.89731089 |
| 49 | Menorrhagia (HP:0000132) | 2.86936857 |
| 50 | Abnormality of B cell number (HP:0010975) | 2.85514432 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 2.81914060 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.81268602 |
| 53 | Increased IgE level (HP:0003212) | 2.80580854 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.80491276 |
| 55 | Diaphragmatic weakness (HP:0009113) | 2.80053065 |
| 56 | Increased mean platelet volume (HP:0011877) | 2.78552563 |
| 57 | Attenuation of retinal blood vessels (HP:0007843) | 2.77739000 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.77689286 |
| 59 | Obstructive lung disease (HP:0006536) | 2.77689286 |
| 60 | Recurrent sinusitis (HP:0011108) | 2.77520439 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.77110025 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.76974417 |
| 63 | Eosinophilia (HP:0001880) | 2.76936905 |
| 64 | Mesangial abnormality (HP:0001966) | 2.76073528 |
| 65 | Vasculitis (HP:0002633) | 2.75759384 |
| 66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.74932663 |
| 67 | Male infertility (HP:0003251) | 2.72173893 |
| 68 | Agnosia (HP:0010524) | 2.71411108 |
| 69 | B lymphocytopenia (HP:0010976) | 2.71393019 |
| 70 | Anomalous pulmonary venous return (HP:0010772) | 2.71086536 |
| 71 | Combined immunodeficiency (HP:0005387) | 2.64125007 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.60804827 |
| 73 | Leukocytosis (HP:0001974) | 2.60804386 |
| 74 | Dry hair (HP:0011359) | 2.60774455 |
| 75 | Abnormal platelet function (HP:0011869) | 2.60103255 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.60103255 |
| 77 | Pustule (HP:0200039) | 2.57324363 |
| 78 | Disinhibition (HP:0000734) | 2.56186992 |
| 79 | Pendular nystagmus (HP:0012043) | 2.54482728 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.53796933 |
| 81 | Abnormality of male internal genitalia (HP:0000022) | 2.52929483 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.51782655 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.50153440 |
| 84 | Recurrent cutaneous fungal infections (HP:0011370) | 2.50153440 |
| 85 | Urticaria (HP:0001025) | 2.47523536 |
| 86 | Recurrent pneumonia (HP:0006532) | 2.47478968 |
| 87 | Hyperlipoproteinemia (HP:0010980) | 2.45897419 |
| 88 | Nasal polyposis (HP:0100582) | 2.45886628 |
| 89 | Abnormality of eosinophils (HP:0001879) | 2.45564775 |
| 90 | Papilloma (HP:0012740) | 2.42781675 |
| 91 | Verrucae (HP:0200043) | 2.42781675 |
| 92 | Abolished electroretinogram (ERG) (HP:0000550) | 2.41843063 |
| 93 | Prolonged bleeding time (HP:0003010) | 2.39484921 |
| 94 | Orchitis (HP:0100796) | 2.38299188 |
| 95 | Abnormality of the pulmonary veins (HP:0011718) | 2.35208476 |
| 96 | Axonal loss (HP:0003447) | 2.34278190 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.33813700 |
| 98 | Abnormality of the prostate (HP:0008775) | 2.33514280 |
| 99 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.32536461 |
| 100 | Abnormality of the fingertips (HP:0001211) | 2.31522697 |
| 101 | Recurrent lower respiratory tract infections (HP:0002783) | 2.30254253 |
| 102 | Encephalitis (HP:0002383) | 2.29789015 |
| 103 | Pulmonary fibrosis (HP:0002206) | 2.29501207 |
| 104 | Progressive visual loss (HP:0000529) | 2.26285676 |
| 105 | Stridor (HP:0010307) | 2.26226055 |
| 106 | Fatigue (HP:0012378) | 2.25126790 |
| 107 | Emphysema (HP:0002097) | 2.24491121 |
| 108 | Chest pain (HP:0100749) | 2.24015684 |
| 109 | IgG deficiency (HP:0004315) | 2.23750982 |
| 110 | Osteomyelitis (HP:0002754) | 2.23655005 |
| 111 | Nephritis (HP:0000123) | 2.23613022 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 2.23395269 |
| 113 | Epistaxis (HP:0000421) | 2.23200126 |
| 114 | Thyroiditis (HP:0100646) | 2.23192757 |
| 115 | Abnormality of T cells (HP:0002843) | 2.22896877 |
| 116 | Hypergammaglobulinemia (HP:0010702) | 2.21088607 |
| 117 | Joint swelling (HP:0001386) | 2.20994076 |
| 118 | Retrobulbar optic neuritis (HP:0100654) | 2.20697876 |
| 119 | Optic neuritis (HP:0100653) | 2.20697876 |
| 120 | Pulmonary infiltrates (HP:0002113) | 2.20496228 |
| 121 | Mucopolysacchariduria (HP:0008155) | 2.19750647 |
| 122 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19750647 |
| 123 | Hypochromic anemia (HP:0001931) | 2.17415840 |
| 124 | Papilledema (HP:0001085) | 2.17230934 |
| 125 | IgA deficiency (HP:0002720) | 2.16945194 |
| 126 | Abnormality of the peritoneum (HP:0002585) | 2.15860127 |
| 127 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15732666 |
| 128 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15732666 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15732666 |
| 130 | Chorioretinal atrophy (HP:0000533) | 2.15217858 |
| 131 | Sepsis (HP:0100806) | 2.12755256 |
| 132 | Lymphoma (HP:0002665) | 2.12608238 |
| 133 | Gingivitis (HP:0000230) | 2.12161328 |
| 134 | Spontaneous hematomas (HP:0007420) | 2.11248254 |
| 135 | Glomerulopathy (HP:0100820) | 2.09967377 |
| 136 | Complement deficiency (HP:0004431) | 2.08602701 |
| 137 | Skin rash (HP:0000988) | 2.07529215 |
| 138 | Macular degeneration (HP:0000608) | 2.06754453 |
| 139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06052828 |
| 140 | Retinal atrophy (HP:0001105) | 2.05889281 |
| 141 | Hepatosplenomegaly (HP:0001433) | 2.05524394 |
| 142 | Photophobia (HP:0000613) | 2.03069487 |
| 143 | Basal ganglia calcification (HP:0002135) | 2.02754734 |
| 144 | Acute hepatic failure (HP:0006554) | 2.02729895 |
| 145 | Abnormality of complement system (HP:0005339) | 2.02500558 |
| 146 | Hematochezia (HP:0002573) | 2.00604500 |
| 147 | Episodic fever (HP:0001954) | 1.98970759 |
| 148 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.98563777 |
| 149 | Keratoconjunctivitis sicca (HP:0001097) | 1.95234957 |
| 150 | Hypoplasia of the thymus (HP:0000778) | 1.94166422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.46982898 |
| 2 | TGFBR2 | 4.26366086 |
| 3 | KIT | 2.96660505 |
| 4 | TYK2 | 2.89990029 |
| 5 | CSF1R | 2.79410698 |
| 6 | TXK | 2.72589670 |
| 7 | PRPF4B | 2.63379370 |
| 8 | BLK | 2.57452039 |
| 9 | IRAK4 | 2.45873003 |
| 10 | ZAP70 | 2.41851140 |
| 11 | RIPK4 | 2.36709159 |
| 12 | TAOK3 | 2.29766893 |
| 13 | IKBKE | 2.28720251 |
| 14 | TBK1 | 2.28378508 |
| 15 | MAP3K14 | 2.16141543 |
| 16 | TESK2 | 2.04621084 |
| 17 | BTK | 2.00771068 |
| 18 | PKN2 | 1.90770798 |
| 19 | STK10 | 1.87284926 |
| 20 | JAK3 | 1.86672187 |
| 21 | SYK | 1.86550645 |
| 22 | MOS | 1.78748314 |
| 23 | TEC | 1.75301749 |
| 24 | IKBKB | 1.73783654 |
| 25 | GRK7 | 1.70757014 |
| 26 | EEF2K | 1.65170191 |
| 27 | MAP2K3 | 1.53357643 |
| 28 | LYN | 1.51229419 |
| 29 | RPS6KA4 | 1.48407189 |
| 30 | BMPR2 | 1.40551222 |
| 31 | FLT3 | 1.40342998 |
| 32 | JAK1 | 1.37568321 |
| 33 | GRK1 | 1.34166945 |
| 34 | TAOK2 | 1.32461662 |
| 35 | HCK | 1.29929385 |
| 36 | LCK | 1.27821514 |
| 37 | ITK | 1.27491321 |
| 38 | CLK1 | 1.26629131 |
| 39 | MAP3K6 | 1.23548364 |
| 40 | FES | 1.16534770 |
| 41 | KDR | 1.16199114 |
| 42 | NME2 | 1.14602174 |
| 43 | ERN1 | 1.14316010 |
| 44 | SIK2 | 1.14301619 |
| 45 | SCYL2 | 1.06012729 |
| 46 | IRAK3 | 1.05447028 |
| 47 | NEK9 | 1.01654692 |
| 48 | CSK | 1.00711088 |
| 49 | MAP3K13 | 1.00214425 |
| 50 | CDK19 | 0.99154341 |
| 51 | MAP3K11 | 0.98999376 |
| 52 | CHUK | 0.91752182 |
| 53 | PIM1 | 0.89156312 |
| 54 | PASK | 0.85368612 |
| 55 | MAP3K3 | 0.84416857 |
| 56 | PBK | 0.84402323 |
| 57 | KSR2 | 0.83435520 |
| 58 | MAP3K1 | 0.81399075 |
| 59 | MAP2K2 | 0.79518593 |
| 60 | PIK3CG | 0.77133761 |
| 61 | NLK | 0.75994439 |
| 62 | NEK2 | 0.75253655 |
| 63 | CDK3 | 0.73803338 |
| 64 | CDK4 | 0.73728032 |
| 65 | LRRK2 | 0.73132173 |
| 66 | MST4 | 0.72911449 |
| 67 | MATK | 0.72606010 |
| 68 | JAK2 | 0.72456196 |
| 69 | FGR | 0.72414909 |
| 70 | PDK1 | 0.70177912 |
| 71 | ACVR1B | 0.69745594 |
| 72 | TLK1 | 0.69148622 |
| 73 | BMX | 0.68289245 |
| 74 | FGFR3 | 0.68250847 |
| 75 | PDK2 | 0.67709505 |
| 76 | SIK3 | 0.65143748 |
| 77 | TGFBR1 | 0.63305950 |
| 78 | MAPK12 | 0.62702378 |
| 79 | PAK4 | 0.61909147 |
| 80 | MUSK | 0.61486827 |
| 81 | GRK6 | 0.60086886 |
| 82 | PTK2B | 0.59508435 |
| 83 | MAPK7 | 0.59204154 |
| 84 | STK4 | 0.58934341 |
| 85 | PDPK1 | 0.57606019 |
| 86 | CDK9 | 0.55463683 |
| 87 | RPS6KL1 | 0.55234732 |
| 88 | RPS6KC1 | 0.55234732 |
| 89 | CAMKK2 | 0.54703426 |
| 90 | CCNB1 | 0.54427740 |
| 91 | FYN | 0.53918617 |
| 92 | MARK3 | 0.52699060 |
| 93 | HIPK2 | 0.52325741 |
| 94 | TIE1 | 0.52034437 |
| 95 | CAMKK1 | 0.51102266 |
| 96 | SMG1 | 0.50743080 |
| 97 | RAF1 | 0.50601614 |
| 98 | MYLK | 0.49629664 |
| 99 | BCKDK | 0.49150507 |
| 100 | ADRBK2 | 0.49123440 |
| 101 | FGFR4 | 0.48569635 |
| 102 | ARAF | 0.45830035 |
| 103 | TAOK1 | 0.45412007 |
| 104 | PIM2 | 0.45383160 |
| 105 | MAP3K12 | 0.45220917 |
| 106 | NUAK1 | 0.44515991 |
| 107 | EIF2AK2 | 0.43310913 |
| 108 | PRKCQ | 0.43101054 |
| 109 | SIK1 | 0.42841947 |
| 110 | TNK2 | 0.42783879 |
| 111 | PRKCD | 0.38513404 |
| 112 | RPS6KA5 | 0.37862513 |
| 113 | MAP3K7 | 0.37659783 |
| 114 | TSSK6 | 0.37518068 |
| 115 | MAP3K5 | 0.37318097 |
| 116 | CDK8 | 0.36578682 |
| 117 | MAPKAPK3 | 0.36263462 |
| 118 | MAPKAPK2 | 0.35908499 |
| 119 | PRKD2 | 0.35787841 |
| 120 | ABL1 | 0.35600274 |
| 121 | MAPK15 | 0.33729020 |
| 122 | TNIK | 0.33617093 |
| 123 | IGF1R | 0.32994723 |
| 124 | RPS6KA6 | 0.32836844 |
| 125 | RPS6KB2 | 0.32726232 |
| 126 | YES1 | 0.32580779 |
| 127 | VRK1 | 0.32280636 |
| 128 | INSRR | 0.31452318 |
| 129 | MAPK11 | 0.31128600 |
| 130 | STK24 | 0.30415210 |
| 131 | ATR | 0.29213556 |
| 132 | BRAF | 0.29195382 |
| 133 | PRKCH | 0.27901378 |
| 134 | EPHB1 | 0.26961212 |
| 135 | MAPKAPK5 | 0.26897414 |
| 136 | MAPK3 | 0.26871799 |
| 137 | PINK1 | 0.26842666 |
| 138 | MARK2 | 0.26628878 |
| 139 | CAMK1D | 0.26481048 |
| 140 | MAP3K10 | 0.25745916 |
| 141 | MELK | 0.25570834 |
| 142 | EIF2AK3 | 0.25134414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 4.88006235 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.25087936 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.20768820 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.91169760 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.82223679 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.67282972 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.50333150 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.50273481 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48354120 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.45937443 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37216571 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 2.20192250 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18874971 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10617089 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.93176231 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85740260 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80212679 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.72334786 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72239384 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.64478166 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57823109 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52271745 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50274737 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.49524043 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.47418704 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44700995 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.42717566 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.37034170 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34665781 |
| 30 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.33989930 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30912696 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.30390235 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.29709595 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25940643 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19834047 |
| 36 | Homologous recombination_Homo sapiens_hsa03440 | 1.19296641 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.19067609 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18719050 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16877391 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.16798234 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12591458 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12350250 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.11997033 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11702764 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.07131213 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.04748850 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96913483 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.95989000 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95476039 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94243315 |
| 51 | Malaria_Homo sapiens_hsa05144 | 0.93993467 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.89274500 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85923634 |
| 54 | Mismatch repair_Homo sapiens_hsa03430 | 0.85395709 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.83069427 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81532600 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73326795 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73177351 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71787178 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70864969 |
| 61 | Ribosome_Homo sapiens_hsa03010 | 0.70653339 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68013763 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67656364 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.64665779 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.64364551 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.63563011 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61627262 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60572278 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60193279 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58332895 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57290630 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56525973 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55077438 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.54671026 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54542180 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51651445 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49970748 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49040728 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48633724 |
| 80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48044248 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.47489648 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47201472 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46759455 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46665256 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46470601 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46258851 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44858847 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44639740 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44606806 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44434035 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44415337 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42386930 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41543368 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41245488 |
| 95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40609184 |
| 96 | Cell cycle_Homo sapiens_hsa04110 | 0.38628703 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.38344940 |
| 98 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38192494 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35900640 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35056869 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34519672 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32935540 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32839184 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31688226 |
| 105 | Purine metabolism_Homo sapiens_hsa00230 | 0.31131011 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29735148 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29005445 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28417584 |
| 109 | RNA polymerase_Homo sapiens_hsa03020 | 0.27724626 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27541339 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.27223113 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26586761 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26505477 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25708270 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25248782 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25217460 |
| 117 | Basal transcription factors_Homo sapiens_hsa03022 | 0.24320408 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24319242 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23843506 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23709384 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23636817 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22752811 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22172591 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21779297 |
| 125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18766435 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18746982 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.18518863 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18494239 |

